Drug Information Association Logo
« Back to Listing

Field-Based Medical Communications on a Global Scale

Medical Communication, Medical Writing, and Medical Science Liaison

Day & Time:
June 18, 10:30AM - 11:30AM (Pacific Standard Time)

Session Number:

Room Number:



Field-Based Medical Communications on a Global Scale

J. Lynn Bass, PharmD, RPh
Director, Medical Affairs
Jazz Pharmaceuticals, United States

The pharmaceutical industry is challenged with communicating and providing education to both local and global constituents on the risks and benefits of its products. In the field, this communication is often provided by Medical Science Liaisons (MSLs) to a variety of health care providers. Since the inaugural team of MSLs was deployed, the role and function of individual MSL has evolved and pivoted in numerous directions. This evolution has expanded and now includes education on a global basis to a broader base of customers. In this session, we will explore the proper assessment to determine when a global MSL team is essential, evaluate how a MSL team is developed to support global needs with regional implementation considerations, and discuss the challenges of assessing outcomes for these teams.

Learning Objective(s):
Identify when a globally-based MSL team should be deployed; Explainthe composition of this team; Discuss the challenges of providing field MSL services on a global scale.

Presentation(s) & Speaker(s):
Medical Affairs and Their Significant Others
Robin L. Winter-Sperry, MD
President and Chief Executive Officer
Scientific Advantage LLC, United States

MSLs: From Global to Regional Implementation
Geoff Brockway
Director, Global MSL Excellence
AstraZeneca, United Kingdom